European Union leaders are set to debate their strategy in response to President Donald Trump’s trade war, with the likely ...

The chef behind ‘Boustany’ reflects on adapting Palestinian dishes for today’s world — and why honoring their roots still ...

When faced with the myriad diseases and equally numerous targets for potential drugs the company could pursue, Kewalramani ...

Similarly, Aurobindo Pharma is recalling 13,605 bottles of Clorazepate Dipotassium Tablets (3.75 mg and 7.5 mg) from the US market. Clorazepate Dipotassium Tablets are used to treat anxiety.

Nurturing a pharma brand and implementing 'emotional selling' can help a product stand out from the competition. There is a topic that has, surprisingly, been the subject of controversial debate ...

Apellis Pharmaceuticals ( NASDAQ: APLS) announced a new agreement with Sobi (SWOBF) ( OTCPK:SWOBY) involving a capped royalty ...

Takeda Pharmaceuticals said the Food and Drug Administration approved its liquid Gammagard immunoglobulin treatment. The drugmaker said Monday that commercialization of Gammagard Liquid is expected to ...

Apellis and Sobi have amended their partnership agreement for paroxysmal nocturnal hemoglobinuria (PNH) treatment Empaveli, or Aspaveli as it is known in Europe.

Create a human experience of care Digital products in rare diseases will, by design, be user-centred as they aim to connect the dots between medical and emotional circumstances.

Apparently, the sweat for the cut on Friday at the Rocket Classic wasn’t enough anxiety for one tournament, because the race to the finish line on Sunday was ju ...